Name: Latest research reports of Eris Lifesciences Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Eris Lifesciences Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Eris Lifesciences Ltd.

NSE: ERIS | BSE: 540596 | ISIN: INE406M01024 | Industry: Pharmaceuticals
| Mid-range Performer

1639.6000 3.50 (0.21%)

NSE Sep 19, 2025 15:31 PM

49.43% Gain from 52W Low

Volume: 431.9K

High volume today

Eris Lifesciences Ltd.

05 Feb 2025

1639.60

0.21%

Eris Lifesciences (BUY): First player to launch GLP products in India

Buy: Eris Lifesciences Ltd.

Target

BOB Capital Markets Ltd.

Base domestic growth at 12% vs IMP growth of 8% due to new product launches and price increase

Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.